Keywords: abraxane, rights, cost, deepens, abraxis, loss, company

Abraxane rights cost deepens Abraxis' loss

Article | 16 March 2009

Print This

US company Abraxis BioScience's loss deepened more than five-fold, year-on-year for 2008, on costs for the re-purchase of rights to lead ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in